Silence Therapeutics plc (SLNCF)
OTCMKTS
· Delayed Price · Currency is USD
0.9500
+0.4514 (90.53%)
Apr 17, 2025, 11:51 AM EDT
Silence Therapeutics Employees
Silence Therapeutics had 116 employees as of December 31, 2024. The number of employees increased by 7 or 6.42% compared to the previous year.
Employees
116
Change (1Y)
7
Growth (1Y)
6.42%
Revenue / Employee
$372,914
Profits / Employee
-$390,595
Market Cap
148.29M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Endo Inc. | 3,116 |
Elite Pharmaceuticals | 64 |
Glass House Brands | 374 |
Northwest Biotherapeutics | 25 |
CytoDyn | 9 |
American Oncology Network | 1,914 |
Longduoduo Company | 49 |
Silence Therapeutics News
- 6 weeks ago - Silence Therapeutics to Webcast Presentation at the Leerink Partners Global Healthcare Conference - Business Wire
- 7 weeks ago - Silence Therapeutics plc (SLN) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 7 weeks ago - Silence Therapeutics plc 2024 Q4 - Results - Earnings Call Presentation - Seeking Alpha
- 7 weeks ago - Silence Therapeutics PLC (SLNCF) Reports Full Year 2024 Financial Results with Strong Cash ... - GuruFocus
- 7 weeks ago - Silence Therapeutics Reports Full Year 2024 Financial Results and Provides Business Update - Business Wire
- 2 months ago - Redmile Group, LLC Acquires Significant Stake in Silence Therapeutics PLC - GuruFocus
- 2 months ago - Silence Therapeutics to Report Fourth Quarter and Full Year 2024 Results on February 27, 2025 - Business Wire
- 2 months ago - Lombard Odier Asset Management's Strategic Acquisition in Silence Therapeutics PLC - GuruFocus